Oncology Corporate Profile
Ascend is a clinical-stage company developing innovative cancer treatments. The company focuses on identifying disease settings where targeting the disease microenvironment or key cell types can bring about meaningful improvements in clinical outcomes.
|Brand / Product||Class||Area of Study||Phase||Partnership|
|ASN-202||immunotherapy||Diffuse Large B-Cell Lymphoma (DLBCL)||II|
|ASN-202||immunotherapy||Basal Cell Carcinoma (BCC)||I|
|ASN-004||immunotherapy||Various cancer types||Preclinical|
View additional information on product candidates here »